Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.
Pediatr Infect Dis J
; 40(8): 774-781, 2021 08 01.
Article
in En
| MEDLINE
| ID: mdl-34250977
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Combined
/
Dengue Vaccines
/
Patient Safety
/
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
/
Immunogenicity, Vaccine
Type of study:
Clinical_trials
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
En
Journal:
Pediatr Infect Dis J
Journal subject:
DOENCAS TRANSMISSIVEIS
/
PEDIATRIA
Year:
2021
Document type:
Article
Affiliation country:
Malaysia
Country of publication:
United States